Long-term of 10 Years Results of a Prospective Longitudinal Study
Usefulness of Home Blood Pressure Measurement in the Morning in Type 2 Diabetic Patients : Long-term (10 Years) Results of a Prospective Longitudinal Study
Previous cross-sectional studies have demonstrated that blood pressure (BP) measurements at home (HBP) in the morning offer stronger predictive power for micro- and macrovascular complications in patients with type 1 and 2 diabetes than casual/clinic blood pressure measurements (CBP) (Kamoi K et al, 2002-2003). Further, a prospective, longitudinal study for 6 years in patients with type 2 diabetes also demonstrated that control of wakening-up HBP provides the stronger predictive power for the outcomes than that of CBP did (Kamoi et al, 2010).
However, it is not clear to show which of BP measurement provides the stronger predictive power for outcomes by comparing cumulative events over a longer time than 6 years. Therefore, the investigators examined which of HBP or CBP provides the stronger predictive power for outcomes in addition of renal anemia reported previously over 10 years in the patients with type 2 diabetes.
調査の概要
状態
研究の種類
入学 (予想される)
連絡先と場所
研究場所
-
-
Niigata
-
Nagaoka、Niigata、日本、940-2085
- Nagaoka Red Cross Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- After a detailed baseline examination, 400 Japanese subjects with type 2 diabetes reported previously are followed up for all-cause mortality and morbidity.
Exclusion Criteria:
- Other than the above, patients judged inappropriate as the subjects of this study by the investigator
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
---|---|
1. Morning HP and NT
Subjects based on HBP were divided into MH and MN patients
|
To clarify which of HBP or CBP provides the stronger prediction power for the outcomes.
To clarify which of HBP or CBP provides the stronger predictive power for the outcomes
|
2. Clinic HP and NT
Subjects based on CBP were divided into CH and CN patients
|
To clarify which of HBP or CBP provides the stronger prediction power for the outcomes.
To clarify which of HBP or CBP provides the stronger predictive power for the outcomes
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Death
時間枠:Average time is 10 years
|
Number of participats not alive
|
Average time is 10 years
|
二次結果の測定
結果測定 |
時間枠 |
---|---|
Microvascular complications including renal anemia
時間枠:Average time is 10 years
|
Average time is 10 years
|
Macrovascular complications
時間枠:Average time is 10 years
|
Average time is 10 years
|
協力者と研究者
捜査官
- 主任研究者:Kyuzi Kamoi, MD、Nagaoka Red Cross Hospital
出版物と役立つリンク
一般刊行物
- Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O. Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care. 2002 Dec;25(12):2218-23. doi: 10.2337/diacare.25.12.2218.
- Kamoi K, Imamura Y, Miyakoshi M, Kobayashi C. Usefulness of home blood pressure measurement in the morning in type 1 diabetic patients. Diabetes Care. 2003 Aug;26(8):2473-5. doi: 10.2337/diacare.26.8.2473. No abstract available.
- Kamoi K, Ito T, Miyakoshi M, Minagawa S. Usefulness of home blood pressure measurement in the morning in patients with type 2 diabetes: long-term results of a prospective longitudinal study. Clin Exp Hypertens. 2010 May;32(3):184-92. doi: 10.3109/10641960903254513.
研究記録日
主要日程の研究
研究開始
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。